Cargando…
A model of long-term survival following adjuvant therapy for stage 2 breast cancer.
Following adjuvant therapy for breast cancer, some patients will die of this tumour while the remainder will die of other causes. Deaths from breast cancer tend to follow a lognormal distribution, while deaths from other causes can be approximated by national demographic data. By combining these two...
Autores principales: | Gamel, J. W., Vogel, R. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968633/ https://www.ncbi.nlm.nih.gov/pubmed/8260368 |
Ejemplares similares
-
Assessing the impact of adjuvant therapy on cure rate for stage 2 breast carcinoma.
por: Gamel, J. W., et al.
Publicado: (1993) -
The Clinical Benefit of Adjuvant Therapy in Long-Term Survival of Early-Stage Ampullary Carcinoma: A Single Institutional Experience
por: Manne, Ashish, et al.
Publicado: (2020) -
A dog with extraskeletal osteosarcoma of the salivary glands survived long-term, following surgical resection and adjuvant therapy
por: UMEDA, Naoki, et al.
Publicado: (2023) -
Long-term survival and cure model following liver resection for breast cancer metastases
por: Ruiz, Aldrick, et al.
Publicado: (2018) -
The long-term survival of stage IV gastric cancer patients with conversion therapy
por: Yamaguchi, Kazuya, et al.
Publicado: (2017)